Cardiac risk in non-cardiac surgery: A review

Despite optimal surgical and medical care, around one million patients worldwide will die annually shortly after having undergone a surgical procedure. A major contributor to this postoperative mortality are “silent myocardial ischemic events” which often go unrecognized. Routine measurement of cardiac biomarkers is an important step in the identification of high risk patients and in improving their perioperative care. Once an ischemic event has occurred, a multidisciplinary approach should guide management (e.g. optimization of anti-ischemic and plaque stabilizing therapy, anticoagulation, antiplatelet therapy or invasive strategies), keeping in mind the fragile balance between risk of ischemic events and bleeding.